← back to search

Zlatko Fras

Pomurski muzej Murska Sobota ·
Area of research
Surgery · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Lipoproteins and Cardiovascular Health, Cardiac Health and Mental Health, Diabetes, Cardiovascular Risks, and Lipoproteins, and Cardiac Imaging and Diagnostics.
h-index
37
citations
27,753
works
133
NIH funding
primary concept
Medicine
email

Recent publications

Chronic coronary syndromes without standard modifiable cardiovascular risk factors and outcomes: the CLARIFY registry
European Heart Journal 2024cited by 6position: middledoi
Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)
Progress in Cardiovascular Diseases 2023cited by 70position: middledoi
Transiently achieved very low LDL-cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial
European Heart Journal 2023cited by 46position: middledoi
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Circulation 2022cited by 121position: middledoi
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome
Journal of the American College of Cardiology 2020cited by 564position: middledoi
Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial
European Heart Journal 2020cited by 201position: middledoi
Screening for Glucose Perturbations and Risk Factor Management in Dysglycemic Patients With Coronary Artery Disease—A Persistent Challenge in Need of Substantial Improvement: A Report From ESC EORP EUROASPIRE V
Diabetes Care 2020cited by 79position: middledoi
Socioeconomic characteristics of patients with coronary heart disease in relation to their cardiovascular risk profile
Heart 2020cited by 19position: middledoi
Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries
Atherosclerosis 2019cited by 363position: middledoi
Prioritizing research challenges and funding for allergy and asthma and the need for translational research—The European Strategic Forum on Allergic Diseases
Allergy 2019cited by 58position: middledoi
Incidence of cardiovascular events in patients with stabilized coronary heart disease: the EUROASPIRE IV follow-up study
European Journal of Epidemiology 2018cited by 35position: middledoi
Lp(a) and Cardiovascular Outcomes: an Analysis from the ODYSSEY OUTCOMES Trial
Atherosclerosis Supplements 2018cited by 19position: middledoi
European Society of Cardiology: Cardiovascular Disease Statistics 2017
European Heart Journal 2017cited by 945position: middledoi
Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration
Atherosclerosis Supplements 2016cited by 113position: middledoi
EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries
European Journal of Preventive Cardiology 2015cited by 1,000position: middledoi
Position paper Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel
Archives of Medical Science 2015cited by 382position: middledoi
Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel
Expert Opinion on Drug Safety 2015cited by 161position: middledoi
Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology
Cardiovascular Diabetology 2015cited by 145position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Michael Szarek · SUNY Downstate Health Sciences University4 papers (2018–2023)Philippe Gabríel Steg · Mount Sinai Hospital4 papers (2018–2023)J. Wouter Jukema · University of Palermo4 papers (2018–2023)Deepak L. Bhatt · Technische Universität Dresden4 papers (2018–2023)Rafael Díaz · Estudios Clínicos Latinoamérica4 papers (2018–2023)Robert Pordy · Regeneron (United States)4 papers (2018–2023)Shaun G. Goodman · St. Michael's Hospital4 papers (2018–2023)Vera Bittner · University of Alabama at Birmingham4 papers (2018–2023)Robert A. Harrington · Duke University4 papers (2018–2023)Harvey D. White · University of Auckland4 papers (2018–2023)Doron Zahger · Ben-Gurion University of the Negev3 papers (2018–2020)Philip E. Aylward · South Australian Health and Medical Research Institute3 papers (2018–2020)Peter Sinnaeve · Çevre, Şehircilik ve İklim Değişikliği Bakanlığı3 papers (2018–2020)Andreas M. Zeiher · California Institute for Regenerative Medicine3 papers (2018–2020)Gregory G. Schwartz · Rocky Mountain MS Center3 papers (2020–2023)Sotirios Tsimikas · Vanderbilt University Medical Center2 papers (2020–2020)Angèle Moryusef · Sanofi (United States)2 papers (2018–2020)Corinne Hanotin · Sanofi (France)2 papers (2018–2020)Matthew T. Roe · Clinical Research Institute2 papers (2018–2020)Patrick M. Moriarty · Amsterdam UMC Location University of Amsterdam2 papers (2018–2020)